Por favor, use este identificador para citar o enlazar este ítem:
https://doi.org/10.3390/antiox13010034


Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Bonmatí Carrión, María Ángeles | - |
dc.contributor.author | Rol de Lama, María de los Ángeles | - |
dc.date.accessioned | 2025-05-12T08:30:59Z | - |
dc.date.available | 2025-05-12T08:30:59Z | - |
dc.date.issued | 2023-12-23 | - |
dc.identifier.citation | Antioxidants, 2024, Vol. 13 (1) : 34 | es |
dc.identifier.issn | Electronic: 2076-3921 | - |
dc.identifier.uri | http://hdl.handle.net/10201/154385 | - |
dc.description | © 2023 by the authors. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by/4.0/ This document is the Published Manuscript version of a Published Work that appeared in final form in Antioxidants. To access the final edited and published work see https://doi.org/10.3390/antiox13010034 | es |
dc.description.abstract | In recent years, the role played by melatonin on the gut microbiota has gained increasingly greater attention. Additionally, the gut microbiota has been proposed as an alternative source of melatonin, suggesting that this antioxidant indoleamine could act as a sort of messenger between the gut microbiota and the host. This review analyses the available scientific literature about possible mechanisms involved in this mediating role, highlighting its antioxidant effects and influence on this interaction. In addition, we also review the available knowledge on the effects of melatonin on gut microbiota composition, as well as its ability to alleviate dysbiosis related to sleep deprivation or chronodisruptive conditions. The melatonin–gut microbiota relationship has also been discussed in terms of its role in the development of different disorders, from inflammatory or metabolic disorders to psychiatric and neurological conditions, also considering oxidative stress and the reactive oxygen species-scavenging properties of melatonin as the main factors mediating this relationship. | es |
dc.format | application/pdf | es |
dc.format.extent | 32 | es |
dc.language | eng | es |
dc.publisher | MDPI | es |
dc.relation | This research was funded by the Ministry of Economy and Competitiveness, the Instituto de Salud Carlos III, through a CIBERFES grant (CB16/10/00239) and DiabfrailLatAm (European Union Horizon 2020 research and innovation programme no. 825546) (all co-financed by FEDER). Grant PID2022-136577OB-I00 was financially supported by MCIN/AEI/10.13039/501100011033/FEDER, UE and by “ERDF A way of making Europe”, sponsored by the “European Union” or by the “European Union NextGenerationEU/PRTR”. | es |
dc.rights | info:eu-repo/semantics/openAccess | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Melatonin | es |
dc.subject | Gut microbiota | es |
dc.subject | Obesity | es |
dc.subject | Sleep | es |
dc.subject | Neurodegenerative disorders | es |
dc.subject | Metabolism | es |
dc.subject | Inflamatory bowel disease | es |
dc.title | Melatonin as a mediator of the gut microbiota–host interaction: implications for health and disease | es |
dc.type | info:eu-repo/semantics/article | es |
dc.relation.publisherversion | https://www.mdpi.com/2076-3921/13/1/34 | es |
dc.identifier.doi | https://doi.org/10.3390/antiox13010034 | - |
dc.contributor.department | Fisiología | - |
Aparece en las colecciones: | Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
antioxidants-13-00034-v2-1.pdf | 2,15 MB | Adobe PDF | ![]() Visualizar/Abrir |
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons